Tenax Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Tenax Therapeutics

14/11/2022 22:02

* Tenax Therapeutics Inc  TENX.OQ  reported a quarterly
adjusted
loss of 11 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 10 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Tenax Therapeutics Inc's reported EPS for the quarter was
a loss
of 11 cents​.
    * The mean earnings estimate of analysts had risen by
about 12.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Tenax Therapeutics Inc shares had fallen by 46.5% this
quarter and lost 91.2% so far this year.
    * The company reported a quarterly loss of $2.92 million.
    * Wall Street's median 12-month price target for Tenax
Therapeutics Inc is $4.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.10          -0.11          Missed
 Jun. 30 2022      -0.09          -0.11          Missed
 Dec. 31 2021      -0.16          -0.04          Beat